Sun Pharmaceutical Industries will donate Rs 25 crore worth of Hydroxychloroquine (HCQS), Azithromycin, other related drugs and hand sanitisers to support India’s fight against COVID-19, company statement said.
The national task force for COVID-19 has recommended the prophylactic use of HCQS for high risk population. HCQS is being studied by the World Health Organization (WHO) for use in conjunction with Azithromycin to treat COVID-19, it added.
“The company is committed to working closely with the governments and relevant stakeholders to ensure that there is uninterrupted supply of medicines,” Sun Pharma said in a statement.
The company is constituting a task force to handle the distribution of these products in India, it added.